Pediatr Gastroenterol Hepatol Nutr.  2018 Jan;21(1):59-67. 10.5223/pghn.2018.21.1.59.

Different Criteria for the Definition of Insulin Resistance and Its Relation with Dyslipidemia in Overweight and Obese Children and Adolescents

• Nogueira-de-Almeida CA
• de Mello E

• KMID: 2401774
• DOI: http://doi.org/10.5223/pghn.2018.21.1.59

Abstract

PURPOSE
to compare cut off points corrected for age and gender (COOP) with fixed cut off points (FCOP) for fasting plasma insulin and Homeostatic model assessment-insulin resistance (HOMA-IR) for the diagnosis of IR in obese children and adolescents and their correlation with dyslipidemia.
METHODS
A multicenter, cross-sectional study including 383 subjects aged 7 to 18 years, evaluating fasting blood glucose, plasma insulin, and lipid profile. Subjects with high insulin levels and/or HOMA-IR were considered as having IR, based on two defining criteria: FCOP or CCOP. The frequency of metabolic abnormalities, the presence of IR, and the presence of dyslipidemia in relation to FCOP or CCOP were analyzed using Fisher and Mann-Whitney exact tests.
RESULTS
Using HOMA-IR, IR was diagnosed in 155 (40.5%) and 215 (56.1%) patients and, using fasting insulin, 150 (39.2%) and 221 (57.7%), respectively applying FCOP and CCOP. The use of CCOP resulted in lower insulin and HOMA-IR values than FCOP. Dyslipidemia was not related to FCOP or CCOP. Blood glucose remained within normal limits in all patients with IR. There was no difference in the frequency of IR identified by plasma insulin or HOMA-IR, both for FCOP and CCOP.
CONCLUSION
The CCOP of plasma insulin or of HOMA-IR detected more cases of IR as compared to the FCOP, but were not associated with the frequency of dyslipidemia. As blood glucose has almost no fluctuation in this age group, even in the presence of IR, fasting plasma insulin detected the same cases of IR that would be detected by HOMA-IR.

Keyword

Obesity; Insulin; Child; Adolescent; Dyslipidemias

MeSH Terms

Adolescent*
Blood Glucose
Child*
Cross-Sectional Studies
Diagnosis
Dyslipidemias*
Fasting
Humans
Insulin Resistance*
Insulin*
Obesity
Overweight*
Plasma
Blood Glucose
Insulin

Reference

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384:766–781.

2. de Onis M. Preventing childhood overweight and obesity. J Pediatr (Rio J). 2015; 91:105–107.

3. Nogueira-de-Almeida CA, Benedeti ACGS, Garcia J, Caixe SH. Correlation between ultrasonographic measures of the abdominal adiposity and indicators of obesity in normal and overweight/obesity children. FASEB J. 2016; 30:1165.

4. Nogueira-de-Almeida CA, Caixe SH, Benedeti ACGS, Garcia J. Echocardiography evaluation as a marker of cardiovascular risk on obese children and adolescents. FASEB J. 2016; 30:126.

5. Nogueira-de-Almeida CA, Garcia J, Caixe SH, Benedeti ACGS. Ultrasonographic assessment of the common carotid intima-media complex in normal weight children and in overweight/obese children. FASEB J. 2016; 30:1165.

6. Nogueira-de-Almeida CA, Pires LAF, dos Santos RG. Comparação de indicadores de perfis glicêmico e lipídico entre crianças e adolescentes obesos egressos de serviço público ou privado da cidade de Ribeirão Preto (SP). Medicina. 2016; 49:504–510.

7. Todendi PF, Valim AR, Reuter CP, Mello ED, Gaya AR, Burgos MS. Metabolic risk in schoolchildren is associated with low levels of cardiorespiratory fitness, obesity, and parents' nutritional profile. J Pediatr (Rio J). 2016; 92:388–393.

8. Sekokotla MA, Goswami N, Sewani-Rusike CR, Iputo JE, Nkeh-Chungag BN. Prevalence of metabolic syndrome in adolescents living in Mthatha, South Africa. Ther Clin Risk Manag. 2017; 13:131–137.

9. Harrell JS, Jessup A, Greene N. Changing our future: obesity and the metabolic syndrome in children and adolescents. J Cardiovasc Nurs. 2006; 21:322–330.

10. Maffeis C, Banzato C, Brambilla P, Cerutti F, Corciulo N, Cuccarolo G, et al. Insulin resistance is a risk factor for high blood pressure regardless of body size and fat distribution in obese children. Nutr Metab Cardiovasc Dis. 2010; 20:266–273.

11. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992; 327:1350–1355.

12. Sanches Pde L, Mello MT, Fonseca FA, Elias N, Piano Ad, Carnier J, et al. Insulin resistance can impair reduction on carotid intima-media thickness in obese adolescents. Arq Bras Cardiol. 2012; 99:892–898.

13. Sinaiko A. Obesity, insulin resistance and the metabolic syndrome. J Pediatr (Rio J). 2007; 83:3–4.

14. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350:2362–2374.

15. Zachurzok-Buczyńska A, Klimek K, Firek-Pedras M, Małecka-Tendera E. Are metabolic syndrome and its components in obese children influenced by the overweight status or the insulin resistance? Endokrynol Pol. 2011; 62:102–108.

16. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007; 8:299–306.

17. Pinho AP, Brunetti IL, Pepato MT, de Almeida CAN. Metabolic syndrome in overweight/obese female adolescents. Rev Paul Pediatr. 2012; 30:51–56.

18. Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010; 95:5189–5198.

19. Almeida CA, Pinho AP, Ricco RG, Pepato MT, Brunetti IL. Determination of glycemia and insulinemia and the homeostasis model assessment (HOMA) in schoolchildren and adolescents with normal body mass index. J Pediatr (Rio J). 2008; 84:136–140.

20. García Cuartero B, García Lacalle C, Jiménez Lobo C, González Vergaz A, Calvo Rey C, Alcázar Villar MJ, et al. The HOMA and QUICKI indexes, and insulin and C-peptide levels in healthy children Cut off points to identify metabolic syndrome in healthy children. An Pediatr Barc. 2007; 66:481–490.

21. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005; 115:e500–e503.

22. Mieldazis SF, Azzalis LA, Junqueira VB, Souza FI, Sarni RO, Fonseca FL. Hyperinsulinism assessment in a sample of prepubescent children. J Pediatr (Rio J). 2010; 86:245–249.

23. Moran A, Jacobs DR Jr, Steinberger J, Hong CP, Prineas R, Luepker R, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999; 48:2039–2044.

24. Pastucha D, Filipčíková R, Horáková D, Radová L, Marinov Z, Maliníková J, et al. The incidence of metabolic syndrome in obese Czech children: the importance of early detection of insulin resistance using homeostatic indexes HOMA-IR and QUICKI. Physiol Res. 2013; 62:277–283.

25. Ten S, Maclaren N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004; 89:2526–2539.

26. Jeffery AN, Metcalf BS, Hosking J, Streeter AJ, Voss LD, Wilkin TJ. Age before stage: insulin resistance rises before the onset of puberty: a 9-year longitudinal study (EarlyBird 26). Diabetes Care. 2012; 35:536–541.

27. Moran A, Jacobs DR Jr, Steinberger J, Steffen LM, Pankow JS, Hong CP, et al. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation. 2008; 117:2361–2368.

28. Aradillas-García C, Rodríguez-Morán M, Garay-Sevilla ME, Malacara JM, Rascon-Pacheco RA, Guerrero-Romero F. Distribution of the homeostasis model assessment of insulin resistance in Mexican children and adolescents. Eur J Endocrinol. 2012; 166:301–306.

29. Barja S, Arteaga A, Acosta AM, Hodgson MI. Insulin resistance and other expressions of metabolic syndrome in obese Chilean children. Rev Med Chil. 2003; 131:259–268.

30. Brasil AR. avaliação da reação inflamatória através da dosagem da proteína c-reativa ultra-sensível e prevalência de síndrome metabólica. Belo Horizonte: UFMG. 2006.

31. da Silva RC, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal glucose tolerant brazilian adolescents with family history of type 2 diabetes. Diabetes Care. 2005; 28:716–718.

32. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988; 37:667–687.

33. Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol. 2010; 2:100–106.

34. Salazar MR, Carbajal HA, Espeche WG, Dulbecco CA, Aizpurúa M, Marillet AG, et al. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Diab Vasc Dis Res. 2011; 8:109–116.

35. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007; 85:660–667.

36. Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med. 2002; 19:527–534.

37. Back Giuliano Ide C, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FH. I guidelines of prevention of atherosclerosis in childhood and adolescence. Arq Bras Cardiol. 2005; 85:Suppl 6. 4–36.

38. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010; 10:318.

39. Madeira IR, Bordallo MA, Carvalho CN, Gazolla FM, de Souza FM, de Matos HJ, et al. The role of metabolic syndrome components and adipokines in insulin resistance in prepubertal children. J Pediatr Endocrinol Metab. 2011; 24:289–295.

40. Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L. Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr. 2013; 7:161–165.

41. Angulo N, de Szarvas SB, Mathison Y, Hadad E, González D, Hernández A, et al. Diagnosis of insulin resistance by indirect methods in obese school children. Invest Clin. 2013; 54:149–160.

42. Kim HA, Lee SY, Kwon HS, Lee SH, Jung MH, Han K, et al. Gender differences in the association of insulin resistance with metabolic risk factors among Korean adolescents: Korea National Health and Nutrition Examination Survey 2008-2010. Diabetes Res Clin Pract. 2013; 99:54–62.

43. Romualdo MC, Nóbrega FJ, Escrivão MA. Insulin resistance in obese children and adolescents. J Pediatr (Rio J). 2014; 90:600–607.

44. Tandon N, Garg MK, Singh Y, Marwaha RK. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR). J Pediatr Endocrinol Metab. 2013; 26:1123–1130.